Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test to rule out Alzheimer’s associated amyloid ...

The pivotal phase IIb ALIENTO study met the primary endpoint of a statistically significant reduction in the annualised exacerbation rate (AER) at 52 weeks when astegolimab was given every two weeksTh ...

Roche has nearly 200 potential drugs in development, a third of them based on new chemical compounds, said George Abercrombie, chief executive at Hoffmann-La Roche, the company’s U.S ...

Approval based on INAVO120 data showing the Itovebi™ (inavolisib)-based regimen more than doubled progression-free survival ...

Hoffmann-La Roche vs Autorità Garante della Concurrenza e del Mercato questions for ECJ re appeal against decision that Roche and Novartis had illegal agreement ...

Dublin, Aug. 09, 2017 (GLOBE NEWSWIRE) -- The "Global In Vitro Diagnostics (IVD) Market: Drivers, Opportunities, Trends and Forecasts: 2014 - 2020" report has been added to Research and Markets ...

The Nature Index tracks the affiliations of high-quality scientific articles. Updated monthly, the Nature Index presents research outputs by institution and country. Use the Nature Index to ...

F. Hoffmann-La Roche Digital Transformation Analysis Report 2024: Technology Activities, Innovation Programs, Initiatives, Partnership, Investments & Acquisition Network Map - ResearchAndMarkets.com ...

Group sales grew by 7%1 at constant exchange rates (CER; 4% in CHF), driven by strong demand for medicines.Pharmaceuticals Division sales rose by 10% (6% in CHF), with Phesgo (breast ...